Change Healthcare Future Growth
Future criteria checks 4/6
Change Healthcare is forecast to grow earnings and revenue by 70.4% and 4.7% per annum respectively. EPS is expected to grow by 68.8% per annum. Return on equity is forecast to be 7.8% in 3 years.
Key information
70.4%
Earnings growth rate
68.8%
EPS growth rate
| Healthcare Services earnings growth | 25.5% |
| Revenue growth rate | 4.7% |
| Future return on equity | 7.8% |
| Analyst coverage | Good |
| Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2025 | 3,933 | 23 | 570 | 857 | 6 |
| 3/31/2024 | 3,740 | 4 | 624 | 1,030 | 9 |
| 3/31/2023 | 3,579 | -63 | 361 | 685 | 9 |
| 6/30/2022 | 3,497 | -77 | 380 | 670 | N/A |
| 3/31/2022 | 3,481 | -57 | 421 | 697 | N/A |
| 12/31/2021 | 3,416 | -78 | 282 | 538 | N/A |
| 9/30/2021 | 3,335 | -51 | 304 | 551 | N/A |
| 6/30/2021 | 3,264 | -57 | 282 | 527 | N/A |
| 3/31/2021 | 3,090 | -112 | 340 | 586 | N/A |
| 12/31/2020 | 2,432 | -966 | 137 | 333 | N/A |
| 9/30/2020 | 1,647 | -917 | 3 | 143 | N/A |
| 6/30/2020 | 891 | -969 | -65 | 15 | N/A |
| 3/31/2020 | 197 | -948 | -167 | -154 | N/A |
| 12/31/2019 | N/A | -84 | 0 | 0 | N/A |
| 9/30/2019 | N/A | -147 | 0 | 0 | N/A |
| 6/30/2019 | N/A | -72 | 3 | 3 | N/A |
| 3/31/2019 | N/A | -52 | 3 | 3 | N/A |
| 12/31/2018 | N/A | -70 | 4 | 4 | N/A |
| 9/30/2018 | N/A | 71 | 4 | 4 | N/A |
| 6/30/2018 | N/A | 67 | N/A | N/A | N/A |
| 3/31/2018 | N/A | 61 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1CB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (-0.01%).
Earnings vs Market: 1CB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 1CB is expected to become profitable in the next 3 years.
Revenue vs Market: 1CB's revenue (4.7% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: 1CB's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1CB's Return on Equity is forecast to be low in 3 years time (7.8%).